Protara Therapeutics Inc (TARA)
Operating Cash Flow Growth
-25.62%
Quarterly · Period ending:
TARA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-25.62%period ending
Latest reported-25.62%period ending
TARA Quarterly Cash from Operations YoY % (-153.17% → -25.62%)
Year-over-year change
High-resolution chart · PNG
TARA operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -25.6245% | |
| -45.0622% | |
| -82.1014% | |
| -47.6405% | |
| -59.36% | |
| -41.7574% | |
| -6.9885% | |
| -28.5475% | |
| 18.2929% | |
| 19.4677% | |
| -73.0999% | |
| -22.7043% | |
| -83.6424% | |
| -17.5805% | |
| 27.2332% | |
| 13.772% | |
| 45.9257% | |
| 8.0453% | |
| -2.0839% | |
| -64.8325% | |
| -65.25% | |
| -66.8066% | |
| -521.4791% | |
| -210.2527% | |
| -339.7433% | |
| -408.2496% | |
| -23.173% | |
| 61.1359% | |
| 87.3912% | |
| 74.249% | |
| 84.4935% | |
| 47.2973% | |
| -215.2439% | |
| 26.7114% | |
| -2.1505% | |
| 10.9774% | |
| 41.1131% | |
| -26.4856% | |
| -7.5145% | |
| -70.0767% | |
| -21.087% | |
| -52.1964% | |
| -153.1707% |